Financial Performance - The company's revenue from corporate financing and financial advisory services increased by 144.2% compared to 2024[13]. - The virtual asset brokerage business experienced a significant growth, becoming the main growth engine with a revenue increase of 588.6% compared to 2024[13]. - The company's revenue for the year ended December 31, 2025, was approximately HKD 209.44 million, an increase of about 179.4% compared to HKD 74.96 million for the year ended December 31, 2024[18]. - The net profit for the year ended December 31, 2025, was approximately HKD 59.11 million, a turnaround from a loss of approximately HKD 2.32 million for the year ended December 31, 2024, primarily due to increased revenue from major operating segments[19]. - Revenue from virtual asset trading and related services represented 47.0% and 19.1% of total revenue for the years ending December 31, 2025, and 2024, respectively[34]. - The total revenue for the group increased by 179.4% to approximately HKD 209.44 million for the year ending December 31, 2025, compared to HKD 74.96 million for the previous year[47]. Operational Highlights - The traditional brokerage and margin financing business showed stable growth, with an expanding customer base and improved service quality and trading efficiency[13]. - The company is focused on deepening its market presence in Hong Kong while connecting with mainland and global markets[12]. - The overall business and financial performance exceeded expectations amid a volatile global financial market[7]. - The average daily trading volume on the Hong Kong Stock Exchange was HKD 2,498.0 billion for the year ending December 31, 2025, a 90% increase from HKD 1,318.0 billion for the year ending December 31, 2024[38]. - The company has become the first licensed entity in Hong Kong to hold a license for virtual asset trading, consultation, and asset management services[33]. Cost and Expenses - Commission expenses increased by 500.3% to HKD 56.65 million for the year ended December 31, 2025, compared to HKD 9.44 million for the previous year[18]. - Employee costs rose by 42.0% to HKD 55.82 million for the year ended December 31, 2025, compared to HKD 39.30 million for the previous year[18]. - Other operating expenses increased by 204.4% to HKD 68.06 million for the year ended December 31, 2025, compared to HKD 22.36 million for the previous year[18]. Strategic Initiatives - The company aims to enhance digital services, risk management, and customer experience through increased technology investment[14]. - The company plans to embrace change with an open mindset and enhance competitiveness through solid execution[12]. - The company aims to develop a niche market in the lending sector to better meet investors' financing needs and provide tailored liquidity solutions for corporate and retail clients[29]. - The company is committed to becoming a comprehensive financial service provider, diversifying its revenue sources to mitigate risks associated with market volatility[39]. - The company is focused on business development and strategic planning, with key personnel responsible for overseeing these areas[87]. Governance and Compliance - The company is committed to maintaining compliance and risk management principles to ensure sustainable business growth[14]. - The company emphasizes strong corporate governance, with independent directors providing oversight and independent opinions to the board[104]. - The board consists of seven members, including three executive directors, one non-executive director, and three independent non-executive directors[108]. - The company has fully complied with the corporate governance code as per GEM Listing Rules for the year ending December 31, 2025[106]. - The company has established mechanisms to ensure that the board receives independent opinions and input, with all committees chaired by independent non-executive directors[113]. Risk Management - The risk management system is designed to manage financial and non-financial risks, including liquidity, credit, market, operational, regulatory, and legal risks[169]. - The board is responsible for establishing an effective risk management environment, including identifying, assessing, and managing risks[170]. - The company has a comprehensive governance framework to systematically identify, assess, manage, and monitor risks that could adversely affect its strategic and business objectives[168]. - The company is actively monitoring global and local regulatory changes to mitigate strategic risks and ensure business performance[172]. - Cybersecurity measures are being strengthened through the adoption of globally recognized standards and regular crisis response drills[173]. Human Resources - The group employed 96 full-time employees as of December 31, 2025, an increase from 65 employees as of December 31, 2024[81]. - The company emphasizes equal opportunities in its hiring practices, ensuring no discrimination based on race, gender, age, or other factors[158]. - The gender distribution in senior management is 60% male and 40% female, while the overall team (excluding senior management) has a distribution of 63% male and 37% female[162][163]. Technology and Innovation - The group launched the VictoryX app, the first licensed financial institution app in Hong Kong to offer both securities and virtual asset trading[45]. - The group has established its own R&D team to enhance its service offerings in the virtual asset space, aligning with its strategic goals[42]. - The company has implemented multiple key strategies to address the complexities associated with cryptocurrency reporting, including hiring qualified candidates and improving transaction tracking tools[178].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 上海大眾公用事業（集團）股份有限公司 Shanghai Dazhong Public Utilities (Group) Co., Ltd.* （於中華人民共和國註冊成立的股份有限公司） （股份代號：1635） 截至2025年12月31日止年度 之業績公告 上海大眾公用事業（集團）股份有限公司（「本公司」）董事（「董事」）會（「董事會」）欣然宣佈 本公司及其附屬公司截至2025年12月31日止年度的經審計業績。本公告列載本公司2025 年年報全文，並符合香港聯合交易所有限公司證券上市規則中有關年度業績初步公告附 載的資料的要求。本公司2025年年度報告將於適當時候在香港聯合交易所有限公司的網 站 www.hkexnews.hk 及本公司的網站 www.dzug.cn 上刊載。 承董事會命 上海大眾公用事業（集團）股份有限公司 董事局主席 楊國平 中華人民共和國，上海 2026年3月30日 於本公告日期， ...

Financial Performance - The company's revenue for the year ended December 31, 2025, was RMB 8,101.0 million, representing a year-on-year growth of 57.9%[3] - Gross profit for the same period was RMB 1,491.4 million, with a year-on-year increase of 99.3%[3] - Net profit reached RMB 808.6 million, showing a significant year-on-year growth of 788.4%[3] - The basic and diluted earnings per share for the period were RMB 0.33, reflecting a year-on-year increase of 725.0%[3] - The company's revenue increased from RMB 5,130.3 million for the year ending December 31, 2024, to RMB 8,101.0 million for the year ending December 31, 2025, representing a growth of 57.9%[34] - Net profit surged from RMB 91.0 million in 2024 to RMB 808.6 million in 2025, marking an increase of 788.4%[34] - Earnings per share rose from RMB 0.04 in 2024 to RMB 0.33 in 2025, reflecting a growth of 725.0%[34] Market and Shipment Growth - The company achieved a shipment volume of 19.82 GWh, which is a year-on-year increase of approximately 66.7%[13] - The domestic market for power batteries in China is projected to reach 724 GWh by 2025, maintaining a dominant global position[4] - The global energy storage battery market is expected to grow significantly, with shipments reaching 550 GWh in 2025, a year-on-year increase of 79%[6] - The sales revenue of the company's power battery business reached 7,680.5 million yuan in 2025, representing a year-on-year growth of 64.7%[14] - The company ranked seventh in the domestic market for new energy passenger vehicle installation volume, with a significant increase in market share for lithium iron phosphate batteries and ternary batteries, ranking ninth and sixth respectively[14] Technological Advancements - The company has made significant advancements in battery technology, including improvements in energy density for cathode materials and fast-charging capabilities for anode materials, achieving peak charging rates of 12C and above[20] - The sodium-ion battery system has achieved an energy density of over 170Wh/kg, with products already exported to EU countries for applications in PHEV and UPS scenarios[21] - The company has developed a lithium metal soft pack battery with a capacity of 10Ah, a mass energy density of 515Wh/kg, and a volume energy density of 1100Wh/L, marking a new stage in advanced battery technology[22] - The company has launched a second-generation "three highs and one fast" aviation battery with an energy density exceeding 320Wh/kg, which has been mass-produced and delivered[24] - The company is focusing on the development of lightweight, high-energy density, and high-safety battery systems, collaborating with eVTOL customers for aircraft airworthiness certification[26] Research and Development - The company has submitted a total of 4,426 patent applications, with 2,854 patents granted as of December 31, 2025, ranking third among enterprises in Jiangsu Province for new patents granted in 2025[23] - The company is actively developing new products and technologies, including high-energy phosphate systems and mixed chemical systems, to enhance market competitiveness and meet future demands[20] - The company plans to develop next-generation large-scale energy storage products with capacities exceeding 1,000Ah to meet future long-duration energy storage market demands[32] - Research and development expenses for 2025 were RMB 520,257 thousand, a decrease of 6.5% compared to RMB 556,165 thousand in 2024[92] Financial Position and Assets - The total assets of the company as of December 31, 2025, amounted to RMB 21,155.596 million, an increase from RMB 15,594.231 million in 2024[66] - The company's cash and cash equivalents reached RMB 4,182.585 million, up from RMB 2,199.072 million in 2024, indicating a growth of 90.2%[66] - The total liabilities increased to RMB 13,063.825 million as of December 31, 2025, compared to RMB 9,697.109 million in 2024, marking a rise of 34.5%[67] - The net asset value of the company was RMB 8,091.771 million, up from RMB 5,897.122 million in 2024, reflecting an increase of 37.4%[67] Corporate Governance and Compliance - The audit committee has reviewed the consolidated financial statements for the year ending December 31, 2025, ensuring compliance with applicable accounting principles and regulations[114] - The company has adhered to the corporate governance code since its listing date, ensuring transparency and accountability to shareholders[110] - The financial data for the year ending December 31, 2025, has been audited by Ernst & Young, ensuring accuracy and compliance with Hong Kong auditing standards[115] Future Plans and Market Expansion - The company plans to increase its production capacity by 10GWh by the end of 2025, bringing the total capacity to 35.5GWh, with an additional 15GWh project for high-energy fast-charging batteries underway[27] - The company plans to expand its market presence by entering three new international markets by the end of 2025, aiming for a 15% increase in global sales[122] - Future guidance includes projected revenue growth of 30% year-over-year, driven by new product launches and market expansion[122] - The company is in discussions for potential mergers and acquisitions to enhance its technology portfolio and market reach[121]

Financial Performance - Total revenue for the year ended December 31, 2025, was RMB 1,198.1 million, representing a 43% increase from RMB 839.6 million in 2024[6]. - The company achieved a profit attributable to owners of RMB 101.4 million, a significant turnaround from a loss of RMB 179.0 million in the previous year[8]. - Pre-tax profit for 2025 was RMB 161.9 million, compared to a loss of RMB 162.6 million in 2024[6]. - Operating profit for 2025 was RMB 133,076,000, a significant recovery from an operating loss of RMB 41,640,000 in 2024[111]. - The company reported a net profit of RMB 92,301,000 for 2025, compared to a net loss of RMB 210,659,000 in 2024[111]. - Basic and diluted earnings per share for 2025 were RMB 0.19, recovering from a loss of RMB 0.35 per share in 2024[112]. Revenue Breakdown - Total revenue for the year ending December 31, 2025, reached RMB 1,066,141,000, a significant increase from RMB 777,104,000 in 2024, representing a growth of approximately 37.1%[130]. - The investment management segment achieved a revenue increase of 131.6% to RMB 732.6 million, reflecting enhanced research capabilities[20]. - Retail and brokerage business revenue grew by 55%, accounting for 43% of total revenue, driven by the continued development of the Duoduo Jin App, which had 570,000 registered users, a 47% increase year-on-year[14]. - The geographical breakdown of revenue shows that mainland China contributed RMB 1,013,119,000 in 2025, a substantial increase from RMB 646,831,000 in 2024, indicating strong market growth[134]. Operating Expenses - Operating expenses for the year were RMB 1,065.0 million, up from RMB 881.3 million in 2024, indicating a focus on operational efficiency despite increased costs[6]. - The company reported a significant reduction in operating costs, contributing to improved operational efficiency[11]. - Total operating expenses increased by 20.8% from RMB 881.3 million for the year ending December 31, 2024, to RMB 1,065.0 million for the year ending December 31, 2025[58]. - The company incurred total operating expenses of RMB 435,074,000 in 2025, which included compensation and benefits expenses of RMB 188,978,000[129]. Asset Management - The company maintained a stable asset management scale, with total assets under management at RMB 28.4 billion by year-end[12]. - Total assets decreased to RMB 9,629,927,000 as of December 31, 2025, down from RMB 10,560,579,000 in 2024[113]. - The total fair value of the company's major investment activities as of December 31, 2025, was approximately RMB 3,132.5 million, representing a 5.1% increase from RMB 2,981.1 million as of December 31, 2024[76]. - The company’s total assets amounted to RMB 7,103,327 thousand in 2025, compared to RMB 7,048,752 thousand in 2024, reflecting a growth of about 0.8%[114]. Investment Activities - The group invested approximately RMB 308.3 million in distressed assets, expecting to recover the invested capital within three years or less[15]. - The company approved a budget of USD 100 million for the development of Web3.0 business and investment in cryptocurrency assets over the next two years[78]. - The company reported realized carried interest income of approximately RMB 5.24 million, with cumulative realized carried interest reaching RMB 1.3 billion[12]. - The unrealized carried interest income for the year ending December 31, 2025, was RMB 722,876,000, up from RMB 550,501,000 in 2024, reflecting improved fund performance[131]. Governance and Compliance - The independent auditor has issued a qualified opinion on the consolidated financial statements for the year ending December 31, 2025[105]. - The audit committee has reviewed the audited consolidated financial statements and discussed accounting policies with senior management[99]. - The company has established various committees, including the audit committee, to ensure high standards of corporate governance[100]. - The company’s board of directors includes a mix of executive and independent non-executive members, ensuring diverse governance[188]. Future Strategies - The group plans to continue focusing on core businesses, enhancing professional capabilities, and improving operational quality and profitability resilience[16]. - Future strategies include promoting retail brokerage, wealth management, and asset management, while expanding the customer base and optimizing operational efficiency[16]. - The company plans to continue focusing on expanding its investment management capabilities and enhancing its market presence in mainland China and Hong Kong[131]. Tax and Liabilities - The income tax expenses for the years ended December 31, 2025 and 2024 were RMB 69.6 million and RMB 48.1 million, respectively[68]. - The total liabilities for accounts payable and other payables rose to RMB 878,372,000 in 2025 from RMB 773,192,000 in 2024, with significant increases in salaries and bonuses payable[172]. - The expected credit loss provision for the year ending December 31, 2025, was RMB 49.3 million, compared to RMB 23.1 million for the year ending December 31, 2024[60]. Social Responsibility - The company made charitable donations totaling RMB 1,976,000 in 2025, compared to RMB 160,000 in 2024, indicating a commitment to social responsibility[150].

Financial Performance - Revenue for the year ended December 31, 2025, was HKD 1,435,980, representing a 2.6% increase from HKD 1,399,969 in 2024[2] - Gross profit decreased by 3.2% to HKD 729,560 from HKD 753,355 in the previous year[5] - Profit attributable to owners of the company was HKD 91,938, down 1.2% from HKD 93,099 in 2024[2] - Basic and diluted earnings per share were both HKD 15.61, a decrease of 1.3% from HKD 15.81 in 2024[2] - Operating profit for the year was HKD 85,958, a decline from HKD 113,142 in 2024[5] - Total comprehensive income for the year was HKD 378,481, compared to a loss of HKD 394,464 in 2024[6] - The group reported a profit before tax of HKD 72,886,000 for 2025, down from HKD 98,113,000 in 2024, reflecting a decrease of about 25.6%[16] - The group reported a net profit attributable to shareholders of HKD 91,938,000, a slight decrease from HKD 93,099,000 in the previous fiscal year, impacted by increased R&D spending[43] Dividends - The board proposed a final dividend of HKD 0.023 per share, down from HKD 0.025 in the previous year[2] - The group declared an interim dividend of HKD 0.022 per share for 2025, up from HKD 0.020 per share in 2024, totaling HKD 12,954,000[29] - The proposed final dividend for the year ending December 31, 2025, will be payable to shareholders listed as of June 1, 2026[69] Assets and Liabilities - Non-current assets increased to HKD 2,294,569 from HKD 1,833,281, reflecting growth in long-term investments[7] - Current liabilities rose to HKD 1,130,197 from HKD 771,254, indicating increased short-term financial obligations[7] - Total equity attributable to the company's owners increased to HKD 2,045,802,000 in 2025 from HKD 1,651,799,000 in 2024, representing a growth of 23.9%[8] - The company's total liabilities increased to HKD 2,333,660,000 in 2025 from HKD 1,846,612,000 in 2024, marking a rise of 26.4%[8] - The total assets of the group for 2025 amounted to HKD 3,463,857,000, a significant increase from HKD 2,617,866,000 in 2024, representing a growth of about 32.4%[18] Research and Development - Research and development expenses increased to HKD 110,957 from HKD 83,829, indicating a focus on innovation[5] - Research and development expenses for the patented and generic products segment increased to HKD 92,263,000 in 2025 from HKD 62,034,000 in 2024, marking a rise of approximately 48.7%[16] - The group invested a total of HKD 359,812,000 in R&D activities, which accounted for 25.1% of annual revenue, a significant increase from 13.8% in the previous fiscal year[41] Market and Sales - Over 90% of the group's revenue in 2025 was derived from operations in the People's Republic of China, highlighting the market's significance[20] - The group's revenue from the patented and generic products segment for 2025 was HKD 871,645,000, an increase from HKD 846,732,000 in 2024, representing a growth of approximately 2.5%[16] - The revenue from the introduced products segment for 2025 was HKD 564,335,000, up from HKD 553,237,000 in 2024, indicating a growth of about 2.0%[16] - Sales from introduced products amounted to HKD 564,335,000, accounting for 39.3% of total revenue, while sales from patented and generic products contributed HKD 871,645,000, or 60.7% of total revenue[36] Corporate Governance - The company has adopted the standard code of conduct for securities trading by directors as per the listing rules for the year ending December 31, 2025[71] - The company has complied with the corporate governance code as per the listing rules for the year ending December 31, 2025[72] - The board will continue to review the company's corporate governance practices to ensure compliance with the corporate governance code[73] Future Outlook - The company anticipates continued revenue growth into the fiscal year 2026, despite industry challenges, maintaining a cautiously optimistic outlook[60] - The company is committed to cost control and operational efficiency, ensuring prudent resource allocation and strict management of unnecessary expenses[62] - Research and development investments will focus on projects with clear commercial prospects, exploring licensing opportunities to create additional revenue streams[63] Production and Operations - The manufacturing facilities have improved production capacity and efficiency, achieving a 10% increase in total output for the fiscal year 2025, with pre-filled syringe production rising by 18%[44] - The company is expanding the production scale of the Aripiprazole tablets and has successfully advanced the verification batch production of the fentanyl aerosol inhaler after Phase II clinical trials[45] - The new manufacturing facility in Fremont is a strategic focus, recently starting production of process performance qualification batches, which could become a significant profit growth engine[63] Regulatory Approvals - The FDA approved the supplemental new drug application for ADASUVE® on December 29, 2025, allowing the relocation of commercial manufacturing facilities to Fremont, California, thus diversifying the production network[47] - The company has received regulatory approval for the Cyprofloxacin ear drops, used for treating acute otitis externa and in conjunction with ventilation tube treatment for acute otitis media[54]

Financial Performance - Total revenue for the fiscal year ended December 31, 2025, was HKD 12,044,085 thousand, a decrease of 5.2% from HKD 12,698,567 thousand in 2024[2] - Gross profit for 2025 was HKD 2,431,178 thousand, down 3.4% from HKD 2,517,164 thousand in 2024[2] - Operating profit decreased to HKD 741,792 thousand, a decline of 32.0% compared to HKD 1,090,302 thousand in the previous year[2] - Net profit attributable to equity holders was HKD 143,594 thousand, a significant drop of 70.0% from HKD 479,285 thousand in 2024[2] - Basic and diluted earnings per share for 2025 were HKD 7.13, down from HKD 23.81 in 2024[2] - The company's pre-tax profit for the year ended December 31, 2025, was HKD 567,563, down from HKD 886,730 in 2024, a decrease of 36.0%[15] - The total segment EBITDA for 2025 was HKD 1,452,860, compared to HKD 1,774,627 in 2024, reflecting a decline of 18.1%[14] - Net profit after tax for 2025 was HKD 318.1 million, down 48% from HKD 609.5 million in 2024[22] - EBITDA decreased by 18%, from HKD 1.8 billion to HKD 1.5 billion[22] Comprehensive Income - Total comprehensive income for the year was HKD 1,055,531 thousand, compared to HKD 103,468 thousand in 2024, indicating a substantial increase[3] - Total comprehensive income increased by 920% to HKD 1.06 billion, driven by net investment income of HKD 327 million and favorable foreign exchange gains of HKD 388 million[23] Assets and Liabilities - Non-current assets increased to HKD 15,068,241 thousand from HKD 14,400,824 thousand in 2024, reflecting a growth of 4.6%[4] - Current liabilities rose to HKD 7,864,680 thousand, up from HKD 7,713,866 thousand in 2024, indicating a 2.0% increase[5] - Total equity attributable to equity holders increased to HKD 11,769,985 thousand from HKD 11,052,672 thousand in 2024, a rise of 6.5%[5] - Inventory decreased by HKD 679.8 million compared to the previous year, reflecting a focus on working capital management[24] Revenue Breakdown - Revenue from goods sold decreased to HKD 3,029,462 in 2025 from HKD 3,776,124 in 2024, representing a decline of 19.7%[9] - Revenue from services increased slightly to HKD 7,960,797 in 2025 from HKD 7,907,065 in 2024, a growth of 0.7%[9] - The total fixed rental income from investment properties was HKD 138,753 in 2025, a slight increase from HKD 135,159 in 2024[9] Dividends - The company plans to maintain a final dividend of HKD 0.06 per share for 2025, up from HKD 0.055 in 2024[17] - The board proposed a final dividend of HKD 0.06 per share, totaling HKD 120.8 million, to be paid on June 24, 2026[21] Credit and Risk Management - The group faces credit risk primarily influenced by individual customer characteristics and industry-specific default risks, with a risk management policy that includes credit approval and monitoring[44][45] - The credit risk management framework includes monthly reviews of single debtor/group debtor and industry risk limits[48] - The group has established a credit monitoring process that includes daily communication with clients and monthly reviews of collection rates[54] - As of December 31, 2025, the provision for loan and advance impairment is HKD 60.1 million, up from HKD 47.6 million as of December 31, 2024, with a bad debt write-off rate of less than 0.3% for the year 2025[52] Corporate Governance - The board of directors is committed to high standards of corporate governance to protect shareholder interests and the financial performance of the group[61] - The company has adopted corporate governance guidelines in accordance with the Hong Kong Stock Exchange's listing rules, ensuring compliance with most provisions from the previous year[61] - The current chairman and CEO, Mr. Chen, has significant expertise in the automotive industry, contributing to the group's operations and governance[61] - The board structure includes experienced professionals to balance the chairman's authority, enhancing decision-making efficiency[61] - The board includes both executive and independent non-executive directors, ensuring a diverse governance structure[62] Market Performance - In Singapore, total industry sales volume (TIV) grew by 21% in 2025, with passenger car sales increasing by 22%[30] - Nissan's total sales volume in Singapore fell by 30%, but the after-sales business saw a 15% revenue increase[31] - Subaru's business in Singapore recorded a significant growth of 68% in 2024, outperforming the total industry vehicle (TIV) sales increase[32] - In Hong Kong, despite a 6% increase in TIV, Subaru's sales fell by 17% due to supply constraints, with unfulfilled orders amounting to 117% of the allocated quota by the end of 2025[35] - In mainland China, Subaru's sales dropped by 48% in 2025 compared to 2024, impacted by high inventory levels and intensified price competition[35] - In Taiwan, sales and TIV decreased by 30% and 11% respectively in 2025 due to US tariff adjustments, prompting a strategy to enhance the electric vehicle product line in 2026[36] - In Thailand, Subaru's sales grew by 48% while TIV increased by 10%, following the launch of the new Subaru Forester 2.5[37] - In Vietnam, despite a 20% increase in TIV, Subaru's sales declined by 28%, with demand exceeding supply by 469% for the new Subaru Forester 2.5[38] Operational Efficiency - The group has successfully reduced operating expenses for two consecutive years, further strengthening its ability to respond to short-term challenges[53] - The credit approval team in Singapore employs a comprehensive assessment approach, considering both quantitative and qualitative factors for each loan[46][47] - The group will continue to focus on maintaining a robust financial position and operational momentum while building long-term resilience across its businesses[53] Audit and Compliance - The group's consolidated financial statements for the year ending December 31, 2025, have been audited and confirmed by KPMG, ensuring consistency with the reported amounts[59] - The audit committee has reviewed the financial reports for the group ending December 31, 2025, in collaboration with management[60]

Financial Performance - For the year ended December 31, 2025, operating revenue reached HKD 34.787 billion, an increase of 10.8% compared to HKD 31.387 billion in 2024[15]. - Adjusted EBITDA for the same period reached a historical high of HKD 10.005 billion, up 10.4% from HKD 9.059 billion in 2024[15]. - Profit attributable to the company's owners was HKD 5.075 billion, reflecting a 10.2% increase from HKD 4.603 billion in 2024[15]. - The company reported a significant increase in revenue, achieving a total of $1.2 billion for the quarter, representing a 15% year-over-year growth[59]. - The company provided an optimistic outlook for the next quarter, projecting revenue growth of 10% to 12% based on current market trends and user acquisition strategies[59]. - Total gaming revenue increased by 11.7% to HKD 30.471 billion for the year ended December 31, 2025, compared to HKD 27.283 billion in 2024[105]. - Operating costs increased by 10.7% to HKD 15.353 billion, primarily due to higher gaming taxes and fees[111]. - Employee costs rose by 12.4% to HKD 5.282 billion, attributed to salary adjustments and increased headcount[113]. - The profit attributable to the company's owners increased from HKD 4.6034 billion for the year ending December 31, 2024, to HKD 5.0748 billion for the year ending December 31, 2025, representing a growth of approximately 10.2%[122]. Gaming Operations - The overall gaming market share increased to a record high of 16.1%, compared to 15.8% in the previous year[15]. - Total win from mass gaming tables increased by 10.2% to HKD 31.510 billion, driven by a 1.1% increase in betting volume at MGM Macau and a 14.2% increase at MGM Cotai[15]. - Total win from VIP gaming tables rose by 19.5% to HKD 4.837 billion, despite a decrease in turnover at both MGM Macau and MGM Cotai[15]. - Total win from slot machines increased by 3.3% to HKD 2.296 billion, supported by a 3.1% increase in betting volume at MGM Macau and a 26.5% increase at MGM Cotai[15]. - The company's mass gaming segment accounted for 87% of its gross gaming revenue for the year ending December 31, 2025[83]. - The total win amount from main table games at MGM Macau was HKD 12.775 billion, with a win rate of 22.5%, up from 21.7% in 2024[101]. - The total win amount from slot machines was HKD 995.7 million, with a win rate of 3.3%, down from 3.9% in 2024[101]. Visitor Engagement and Experience - The number of visitors to the properties increased by 14%, with a peak of nearly 111,000 visitors recorded on December 31[24]. - The new immersive experience program "Treasure Box" was launched to enhance customer engagement, with the first exhibition attracting 826,000 visitors last year[30]. - Over 30% of the audience for the "Macau 2049" show, created in collaboration with renowned director Zhang Yimou, came from overseas, highlighting its global appeal[30]. - The company continues to enhance customer experience through renovations and expansions of hotel, dining, and entertainment facilities[86]. - The company has a dedicated team managing credit risk for VIP customers, ensuring timely collection of receivables[85]. Strategic Initiatives and Investments - The company aims to strengthen its creative capabilities and continue investing in assets, talent, and community to maintain its leading position in Macau's transformation into a global diversified tourism destination[31]. - MGM Resorts International has expanded its domestic and international presence, including resort developments in Maryland and Macau, and the T-Mobile Arena in Las Vegas[36]. - The company has created BetMGM to enhance its expansion in the entertainment and sports betting sectors[36]. - The company has invested $50 million in research and development for new technologies aimed at improving operational efficiency and customer experience[59]. - New product launches are expected to contribute an additional $200 million in revenue over the next fiscal year, with a focus on innovative technology solutions[59]. Management and Leadership - William Hornbuckle has been the CEO and President of MGM Resorts International since July 29, 2020, overseeing the company's strategy and operations, including global development and digital gaming strategies[36]. - John M. McManus has served as the Chief Legal and Administrative Officer since September 2022, contributing to the company's governance and compliance efforts[37]. - Jonathan S. Halkyard has served as CFO since January 2021, overseeing all financial activities and investor relations for MGM Resorts International, with prior experience at Extended Stay America and Caesars Entertainment[44]. - Ayesha Khanna Molino was appointed COO of MGM Resorts International in January 2026, bringing significant policy experience from her previous roles in the U.S. Senate and the Department of Commerce[43]. - The leadership team has a strong background in hospitality and finance, with members holding advanced degrees and professional qualifications in their respective fields[39][40]. Community and Social Responsibility - The Golden Lion Volunteer Team contributed over 31,000 hours of community service through 5,800 activities in 2025, emphasizing the company's focus on community welfare[31]. - The company has implemented anti-money laundering policies to comply with all applicable laws and regulations in Macau, but cannot guarantee their effectiveness in preventing illegal activities[198]. - The group’s reputation and brand value are at risk if it fails to address environmental, social, and governance (ESG) concerns adequately[192]. Risks and Challenges - The company faces intense competition in the gaming and hospitality sectors, particularly in Macau, which is expected to increase with new projects coming online[166]. - Economic downturns and uncertainties significantly impact the company's operations, particularly consumer discretionary spending and business travel expenditures[168]. - The group is exposed to risks from external factors such as natural disasters, geopolitical events, and terrorism, which could disrupt travel and negatively affect business performance[174]. - Cybersecurity threats pose risks to the integrity of customer and company data, which could result in significant costs and damage to the group's reputation[188]. - The group faces significant risks related to the inability to establish and protect its intellectual property, which could adversely affect its business, financial condition, and operating performance[181].

Financial Performance - Total revenue increased by 0.65% to RMB 933.6 million for the year ended December 31, 2025, compared to RMB 927.6 million in 2024[5] - Gross profit decreased by 6.53% to approximately RMB 410.9 million, resulting in a gross margin of 44.0%, down 3.4 percentage points from 47.4% in 2024[6] - Net loss narrowed to RMB 55.1 million, an improvement of approximately 9.12% from a net loss of RMB 60.7 million in the previous year[7] - The company reported a pre-tax loss of RMB 40.4 million, an improvement of 28.13% compared to a loss of RMB 56.2 million in the previous year[29] - The group reported a pre-tax loss of RMB 100,268 thousand for the current period, compared to a loss of RMB 105,799 thousand in the previous year[91] - The group reported a total tax expense of RMB 14,764,000 for 2025, a significant increase from RMB 4,491,000 in 2024[101] - The cumulative tax losses generated in mainland China as of December 31, 2025, amounted to RMB 888,229,803, compared to RMB 270,503,294 in 2024[102] - The basic and diluted loss per share for 2025 was RMB (5.92), slightly worse than RMB (5.77) in 2024[106] Revenue Growth Areas - The oncology segment revenue experienced a significant growth of 106.2%, driven by strategic acquisitions and market expansion[5] - The contract research organization (CRO) segment reported a revenue increase of 33.4% during the reporting period[5] - Revenue from tumor testing services surged by 106.2% year-on-year to RMB 44.8 million, becoming a significant growth driver[35] - The revenue from the research services and CRO segment increased by 33.4% to RMB 59.6 million, up from RMB 44.7 million in 2024[36] Strategic Initiatives - The company is focusing on high-level clinical research around its core technology for MRD monitoring, particularly in early-stage lung and breast cancers[10] - Strategic investments in new business segments and operational efficiency measures are showing positive results, stabilizing the operational fundamentals[7] - The company continues to optimize its business structure and expand into new markets despite external pressures from healthcare cost control policies[6] - The company plans to implement a dual-driven strategy focusing on "solid foundation and cutting-edge breakthroughs" to enhance its competitive edge in the evolving medical testing industry[27] - The company aims to strengthen its core specialties while leveraging the "IVD+LDT" dual-track synergy for resource optimization[27] Product Development and Innovation - In 2025, the company achieved a significant milestone with the commercial launch of its lung cancer early screening product, PulmoSeek®Plus, which completed the LDT filing process in collaboration with Guangzhou Medical University First Affiliated Hospital[11] - The UriFind® product for urinary tract cancer testing transitioned from early development to regular procurement, with over 200 hospitals in the development phase and more than 140 authorized hospitals, indicating strong clinical value and future revenue support[12] - The company expanded its non-invasive gastric cancer early detection product, Gastromia®, which received Class III medical device registration approval by the end of 2025, enhancing its comprehensive cancer management capabilities[12] - The company developed multiple high-precision testing projects, including MRD monitoring for acute myeloid leukemia and various genetic mutation tests for multiple myeloma, indicating advancements in its R&D capabilities[16] - The company published 13 research articles and applied for 56 patents in 2025, with 25 patents granted, including 6 invention patents, showcasing its commitment to innovation[15] Operational Efficiency - The company launched the "District Inspection Cloud V2.0" platform, enhancing operational efficiency and reducing error rates in sample testing[26] - The company completed a major upgrade of its T-cell immune function assessment product, increasing the detection capacity by 18 times, and achieved key breakthroughs in digital transformation[18] - The company has implemented strict controls over outstanding receivables to minimize credit risk, with senior management regularly reviewing overdue balances[114] Market Expansion and Partnerships - The company established over 100 new hospital partnerships in the hematology testing services, enhancing its market coverage[9] - The company added 41 new testing items and partnered with 83 new hospitals in the neurology sector, indicating a robust growth strategy in clinical collaboration and resource integration[13] - The company has established a sequencing center in New Zealand, expanding its global service capabilities and providing comprehensive long-read sequencing services[21] Financial Position and Investments - The company has a cash reserve of approximately RMB 1.88 billion as of December 31, 2025, supporting its strategic investments in multi-omics data integration and AI pathology analysis[25] - The company completed the acquisition of 100% equity interest in a target foreign-invested enterprise and 49% equity interest in a target U.S. company for a total consideration of approximately USD 31.30 million, with the transaction closing on January 24, 2025[61] - The company completed the acquisition of 90% equity in Shanghai ZhenGu Biotechnology Co., Ltd. for a total consideration of approximately RMB 20.5 million on March 17, 2026[67] Corporate Governance - The company is committed to maintaining strict corporate governance and has adopted the principles of the corporate governance code[141] - The board believes that the dual role of the chairman and CEO held by Dr. Wong does not affect the balance of power and responsibilities within the board[142] - The audit committee has reviewed the consolidated financial statements for the fiscal year ending December 31, 2025, confirming compliance with applicable accounting standards[144] - The board has proposed amendments to the Articles of Association to comply with the latest regulatory requirements, including provisions for a stock repurchase scheme[153] Shareholder Returns - The company has established a dividend policy, planning to distribute a total of at least HKD 300 million in cash dividends for the fiscal years 2025-2027, including approximately HKD 100 million for the fiscal year 2025[146] - The proposed final dividend for the year ending December 31, 2025, is HKD 0.095 per share, pending shareholder approval[103]

Financial Performance - Revenue for the year ended December 31, 2025, was $45,114,000, an increase of 7.7% from $42,795,000 in 2024[4] - Operating loss decreased to $12,954,000 from $14,454,000, reflecting an improvement in operational efficiency[4] - Loss attributable to owners of the company was $16,579,000, down from $18,955,000 in the previous year, indicating a reduction in net losses[5] - Gross margin improved to -36.7% from -44.3%, showing better cost management and revenue generation[4] - Basic loss per share improved to -4.6 cents from -5.3 cents, reflecting a positive trend in financial performance[5] - Total revenue for the year ending December 31, 2025, is projected to be $45,114,000, an increase from $42,795,000 in 2024, representing a growth of approximately 5.8%[21] - The total loss before tax for the year ending December 31, 2025, is expected to be $16,840,000, an improvement from a loss of $19,081,000 in 2024[21] - The pre-tax loss for the group was $16,579,000 in 2025, compared to a loss of $18,955,000 in 2024, indicating an improvement of 12.5%[34] Assets and Liabilities - Total assets decreased to $128,035,000 from $140,114,000, primarily due to a reduction in non-current assets[6] - Current liabilities net amount was $40,250,000, with significant loans for hotel renovations in Guam and Saipan[10] - Cash and cash equivalents increased to $3,566,000 from $3,192,000, indicating improved liquidity[6] - The company reported a net current liability of $40,250,000 as of December 31, 2025, with a net loss of $16,840,000 for the year[82] - The group has a total of $35,200,000 in interest-bearing term loans and $5,000,000 in revolving loans as of December 31, 2025, with a repayment schedule indicating approximately $15,833,000 due in 2026 and $19,367,000 due in 2027[70] Financing and Funding - The group has obtained a total of $52,700,000 in shareholder loan financing from Tan Holdings, with $43,600,000 drawn as of December 31, 2025[12] - The repayment terms for two of the shareholder loans totaling $15,000,000 have been amended to have no fixed maturity date, allowing the company to decide on repayments at its discretion[12] - The group has received a written commitment from Tan Holdings for an additional $9,000,000 standby shareholder loan financing[12] - The group has received a commitment letter from Tan Holdings for a standby shareholder loan of $9,000,000 as of March 2026, ensuring financial support for debt repayment[71] - The group has utilized a total of $48,000,000 in bank financing, secured against several properties as of December 31, 2025[73] - The group has entered into seven loan agreements with Tan Holdings since 2022, totaling $52,000,000 in unsecured, interest-bearing loans[70] Operational Segments - The group operates primarily in Saipan, Guam, and Hawaii, with three reportable operating segments: Hotels and Resorts, Premium Travel Retail, and Destination Services[17] - Performance evaluation of the operating segments is based on adjusted profit/loss before tax, excluding financial income, financial costs, and corporate expenses[18] - The segment revenue from hotels and resorts is expected to reach $36,470,000 in 2025, up from $34,458,000 in 2024, indicating a growth of about 5.8%[21] - The luxury travel retail segment is projected to generate $7,593,000 in 2025, compared to $7,414,000 in 2024, reflecting an increase of approximately 2.4%[21] - The destination services segment is anticipated to grow to $1,051,000 in 2025 from $923,000 in 2024, marking a significant increase of around 14%[21] Visitor Trends and Market Insights - The number of visitors to Guam increased by 5.9% in 2025, totaling approximately 783,000 visitors, which is 47% of the pre-pandemic levels in 2019[40] - South Korea remained the largest source market for visitors to Guam, accounting for 48.7% of total visitors in 2025, with a 1.7% increase from the previous year[40] - Saipan's visitor numbers decreased by 35.4% compared to last year, with South Korean visitors down by 41.5%[42] - The company continues to focus on expanding its market share in the tourism industry in Guam and Saipan, supported by the Guam Visitors Bureau's marketing initiatives[59] - The number of Chinese mainland tourists traveling to Saipan via Hong Kong continues to grow, with ongoing discussions to increase direct flights from Hong Kong to Saipan[60] Cost Management and Efficiency - The company implemented effective cost-saving measures, which contributed to the reduction in operating losses[46] - The company is focused on improving average room rates and operational efficiency at its two Crowne Plaza resorts, while also implementing effective cost-saving measures[61] - The total employee cost for the year was $14,528,000, slightly down from $14,613,000 in 2024, with a total of 329 full-time employees as of December 31, 2025[75] Corporate Governance and Compliance - The group has maintained compliance with all applicable corporate governance codes throughout the year[78] - The independent auditor, Ernst & Young, has reviewed the group's consolidated financial statements and found them to be prepared in accordance with applicable accounting standards[81] - The company has established various communication channels to enhance transparency and maintain investor relations, including regular updates on its website[68] Future Outlook and Strategic Initiatives - The company plans to enhance cash flow through measures such as accelerating the collection of receivables and controlling capital expenditures[10] - The group will consider obtaining additional funding sources as needed to improve its financial position and support operations[12] - Guam's tourism outlook for 2026 is positive, supported by strong outbound travel from Japan, South Korea, and Taiwan, along with marketing initiatives by the Guam Visitors Bureau[62] - The Marianas Visitors Authority has approved a $3.8 million spending plan for 2026, prioritizing core tourism promotion activities in Saipan[63] - The company continues to explore potential acquisition opportunities to ensure long-term growth and maximize shareholder value[67]

Financial Performance - Total revenue for the year ended December 31, 2025, was RMB 287,077,000, a decrease of 4.9% compared to RMB 301,937,000 in 2024[3] - Gross profit for 2025 was RMB 143,916,000, down 9.0% from RMB 158,159,000 in 2024[3] - Net profit for the year was RMB 67,427,000, a decline of 16.1% from RMB 80,415,000 in 2024[3] - Basic and diluted earnings per share for 2025 were RMB 10.63, compared to RMB 11.09 in 2024, reflecting a decrease of 4.1%[3] - The group reported a total profit before tax of RMB 82,314,000 for the year ending December 31, 2025, compared to RMB 98,081,000 in 2024, reflecting a decrease of 16.1%[20] - The total annual profit attributable to the company's owners decreased from RMB 77,643,000 in 2024 to RMB 74,410,000 in 2025, a decline of approximately 4.3%[30] - The total costs and expenses for the year ending December 31, 2025, were approximately RMB 203,795,000, a slight decrease of about 0.2% from RMB 204,178,000 in the previous year[58] Assets and Liabilities - Total assets as of December 31, 2025, were RMB 328,792,000, down from RMB 405,671,000 in 2024, indicating a reduction of 19.0%[4] - Current liabilities increased to RMB 231,095,000 in 2025 from RMB 221,724,000 in 2024, representing a rise of 4.0%[4] - Non-current liabilities, specifically lease liabilities, rose to RMB 4,861,000 in 2025 from RMB 3,106,000 in 2024, an increase of 56.5%[5] - Shareholders' equity decreased to RMB 127,606,000 in 2025 from RMB 212,791,000 in 2024, a decline of 40.0%[5] - The total liabilities of the group increased to RMB 235,956,000 in 2025 from RMB 224,830,000 in 2024[22] Revenue Breakdown - Revenue from decision consulting services increased to RMB 172,751,000 in 2025, up from RMB 171,284,000 in 2024, representing a growth of 0.9%[15] - Revenue from data platform services significantly decreased to RMB 18,989,000 in 2025, down 50.7% from RMB 38,446,000 in 2024[15] - Revenue from the science and technology innovation platform services rose to RMB 95,337,000 in 2025, compared to RMB 92,207,000 in 2024, marking a growth of 3.0%[15] - Revenue from decision-making consulting services was approximately RMB 172,751,000, accounting for about 60% of total revenue, an increase of about 1% from RMB 171,284,000 in the previous year[57] - Revenue from data platform services was approximately RMB 18,989,000, accounting for about 7% of total revenue, a significant decrease of about 51% from RMB 38,446,000 in the previous year[55] - Revenue from innovation platform services was approximately RMB 95,337,000, accounting for about 33% of total revenue, an increase of about 3% from RMB 92,207,000 in the previous year[56] Cash and Investments - The company reported a net cash balance of RMB 289,850,000 as of December 31, 2025, down from RMB 358,735,000 in 2024, a decrease of 19.2%[4] - Cash and bank balances as of December 31, 2025, were approximately RMB 289,850,000, a decrease of about 19% from RMB 358,735,000 in the previous year[61] - Interest income from bank deposits decreased from RMB 2,202,000 in 2024 to RMB 1,240,000 in 2025, a decline of approximately 43.7%[26] Governance and Compliance - The company has adopted the corporate governance code as per the Hong Kong Stock Exchange's listing rules, ensuring compliance with applicable governance standards[77] - The audit committee, consisting of three independent non-executive directors, has reviewed the annual performance and financial statements, confirming compliance with applicable accounting standards[82] - The company confirms that all directors and supervisors have adhered to the securities trading standards set forth in the listing rules for the year ending December 31, 2025[78] - The company maintains a public float of at least 25% of its issued share capital as of the announcement date[80] Future Outlook and Strategy - The company aims to shift its development model in 2026 from focusing on quantity and scale growth to enhancing quality and influence, targeting sustainable growth[50] - The company plans to enhance operational stability by improving governance and internal control mechanisms, focusing on risk identification and management[51] - The group plans to continue evaluating the impact of the new Hong Kong Financial Reporting Standard No. 18 on its consolidated financial statements[14] Shareholder Information - The company proposed a final dividend of RMB 0.09 per share for 2025, down from RMB 0.11 per share in 2024, representing a decrease of approximately 18.2%[31] - The proposed final dividend for the year ending December 31, 2025, is RMB 0.09 per share, totaling RMB 63,000,000 (tax included) if approved by shareholders[74] - The annual general meeting for 2025 will be held on May 18, 2026, with a suspension of share transfer registration from May 13 to May 18, 2026, to determine eligible shareholders[83] - The final dividend payment is expected to be made around June 30, 2026, pending shareholder approval at the annual general meeting[85] Operational Developments - The company continues to focus on providing decision-making consulting services, data platform services, and technology innovation platform services[6] - The company has established a "four-in-one" integrated service model, focusing on consulting, innovation, digitalization, and investment financing to enhance service capabilities and market influence[44][45] - The digital product system has been improved, with products like "CIDI Investment Promotion" and "CIDI Talent Connection" completed and in use, supporting multiple government departments[49] Accounts Receivable and Impairment - The net amount of accounts receivable increased from RMB 40,239,000 in 2024 to RMB 37,418,000 in 2025, reflecting a decrease of about 4.5%[33] - The impairment loss on accounts receivable increased from RMB 4,401,000 in 2024 to RMB 7,524,000 in 2025, an increase of about 70.1%[33] - The total accounts receivable impairment loss increased to RMB 7,524,000 in 2025 from RMB 4,401,000 in 2024, reflecting a rise of 70%[38] - The expected loss rate for low-risk customers is 0.32% for 0-60 days, with a total amount of RMB 27,607,000 and a loss provision of RMB 207,000[36] - High-risk customers show a significant increase in expected loss rates, with 100% for over 365 days, totaling RMB 3,997,000 and a loss provision of RMB 3,997,000[36] Legal and Recovery Actions - The company has taken legal action to recover overdue accounts receivable, indicating proactive measures in financial management[38]